122 related articles for article (PubMed ID: 15856463)
21. Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.
Kuo SH; Yang SY; You SL; Lien HC; Lin CH; Lin PH; Huang CS
Oncotarget; 2017 Mar; 8(13):20925-20938. PubMed ID: 28178648
[TBL] [Abstract][Full Text] [Related]
22. Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
Kawada K; Taira N; Mizoo T; Suzuki Y; Kajiwara Y; Hatono M; Tsukioki T; Kochi M; Abe Y; Nishiyama K; Iwamoto T; Ikeda H; Shien T; Doihara H; Ishihara S; Kawai H; Kawasaki K; Ishibe Y; Ogasawara Y; Toyooka S
Breast Cancer; 2021 Mar; 28(2):478-487. PubMed ID: 33185851
[TBL] [Abstract][Full Text] [Related]
23. The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival.
Houtsma D; de Groot S; Baak-Pablo R; Kranenbarg EM; Seynaeve CM; van de Velde CJH; Böhringer S; Kroep JR; Guchelaar H-; Gelderblom H
Sci Rep; 2021 Feb; 11(1):3249. PubMed ID: 33547330
[TBL] [Abstract][Full Text] [Related]
24. Variants of estrogen-related genes and breast cancer risk in European and African American women.
Quan L; Hong CC; Zirpoli G; Roberts MR; Khoury T; Sucheston-Campbell LE; Bovbjerg DH; Jandorf L; Pawlish K; Ciupak G; Davis W; Bandera EV; Ambrosone CB; Yao S
Endocr Relat Cancer; 2014; 21(6):853-64. PubMed ID: 25228414
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphims of estrogen receptor alpha -397 PvuII (T>C) and -351 XbaI (A>G) in a portuguese population: prevalence and relation with breast cancer susceptibility.
Ramalhinho AC; Marques J; Fonseca-Moutinho JA; Breitenfeld L
Mol Biol Rep; 2013 Aug; 40(8):5093-103. PubMed ID: 23666105
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Int J Cancer; 2010 Jun; 126(12):2935-46. PubMed ID: 19739075
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor alpha polymorphisms and the risk of malignancies.
Anghel A; Narita D; Seclaman E; Popovici E; Anghel M; Tamas L
Pathol Oncol Res; 2010 Dec; 16(4):485-96. PubMed ID: 20383761
[TBL] [Abstract][Full Text] [Related]
28. Association of PvuII and XbaI polymorphisms on estrogen receptor alpha (ESR1) gene to changes into serum lipid profile of post-menopausal women: Effects of aging, body mass index and breast cancer incidence.
Gomes-Rochette NF; Souza LS; Tommasi BO; Pedrosa DF; Eis SR; Fin ID; Vieira FL; Graceli JB; Rangel LB; Silva IV
PLoS One; 2017; 12(2):e0169266. PubMed ID: 28199328
[TBL] [Abstract][Full Text] [Related]
29. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.
Hefler LA; Tempfer CB; Grimm C; Lebrecht A; Ulbrich E; Heinze G; Leodolter S; Schneeberger C; Mueller MW; Muendlein A; Koelbl H
Cancer; 2004 Jul; 101(2):264-9. PubMed ID: 15241822
[TBL] [Abstract][Full Text] [Related]
30. Genotype distribution of estrogen receptor-alpha, catechol-O-methyltransferase, and cytochrome P450 17 gene polymorphisms in Caucasian women with uterine leiomyomas.
Denschlag D; Bentz EK; Hefler L; Pietrowski D; Zeillinger R; Tempfer C; Tong D
Fertil Steril; 2006 Feb; 85(2):462-7. PubMed ID: 16595228
[TBL] [Abstract][Full Text] [Related]
31. The association between a novel polymorphism (rs1062577) in ESR1 and breast cancer susceptibility in the Han Chinese women.
Chen L; Kang H; Jin GJ; Chen X; Zhang QY; Lao WT; Li R
Gynecol Endocrinol; 2016 Jul; 32(7):553-6. PubMed ID: 26850117
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes.
Fjeldheim FN; Frydenberg H; Flote VG; McTiernan A; Furberg AS; Ellison PT; Barrett ES; Wilsgaard T; Jasienska G; Ursin G; Wist EA; Thune I
BMC Cancer; 2016 Oct; 16(1):776. PubMed ID: 27717337
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor α gene polymorphisms and risk of Alzheimer's disease: evidence from a meta-analysis.
Cheng D; Liang B; Hao Y; Zhou W
Clin Interv Aging; 2014; 9():1031-8. PubMed ID: 25061285
[TBL] [Abstract][Full Text] [Related]
34. Menopausal status modifies breast cancer risk associated with ESR1 PvuII and XbaI polymorphisms in Asian women: a HuGE review and meta-analysis.
Li LW; Xu L
Asian Pac J Cancer Prev; 2012; 13(10):5105-11. PubMed ID: 23244119
[TBL] [Abstract][Full Text] [Related]
35. Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.
Sa-Nguanraksa D; Suntiparpluacha M; Kulprom A; Kummalue T; Chuangsuwanich T; Avirutnan P; O-Charoenrat P
Asian Pac J Cancer Prev; 2016; 17(6):2935-40. PubMed ID: 27356714
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
[TBL] [Abstract][Full Text] [Related]
37. Estrogen receptor quantitative measures and breast cancer survival.
Hill DA; Barry M; Wiggins C; Nibbe A; Royce M; Prossnitz E; Lomo L
Breast Cancer Res Treat; 2017 Dec; 166(3):855-864. PubMed ID: 28825224
[TBL] [Abstract][Full Text] [Related]
38. Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
Tsezou A; Tzetis M; Gennatas C; Giannatou E; Pampanos A; Malamis G; Kanavakis E; Kitsiou S
Breast; 2008 Apr; 17(2):159-66. PubMed ID: 17904846
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
[TBL] [Abstract][Full Text] [Related]
40. Possible difference in frequencies of genetic polymorphisms of estrogen receptor alpha, estrogen metabolism and P53 genes between estrogen receptor-positive and -negative breast cancers.
Hamaguchi M; Nishio M; Toyama T; Sugiura H; Kondo N; Fujii Y; Yamashita H
Jpn J Clin Oncol; 2008 Nov; 38(11):734-42. PubMed ID: 18820009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
